Aprea Therapeutics (APRE) Financials

$0.79

$-0.04 (-5.22%)

As on 09-Sep-2026 16:04EDT

Market cap

$10 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Operating Revenue	0.01	0.29	1.50	0.58	--	--
Cost of Revenue	-4.37	0.02	9.36	0.01	16.40	0.27
Gross Profit	4.37	0.26	-7.86	0.58	-16.40	-0.27
Operating Expenses	13.22	13.23	6.46	16.05	96.99	37.17
Operating Profit (EBIT)	-13.22	-13.23	-14.32	-15.47	-113.39	-37.45
Other Income	--	--	--	--	--	--
Profit before Tax	-12.31	-12.60	-12.96	-14.29	-112.66	-37.13
Provision for Tax	--	--	--	0.00	112.21	-0.59
Profit after Tax (Net Income)	-12.31	-12.60	-12.96	-14.29	-112.66	-36.54
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-112.66	-37.13

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Shareholder's Funds	38.47	12.44	19.31	18.26	25.64	49.51
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.73	0.73	1.31	1.31	1.31	1.96
Current Liabilities	3.09	2.76	3.36	4.39	3.20	7.32
Total Liabilities	45.38	15.93	23.98	22.65	30.16	56.82

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Non-Current Assets	0.38	0.37	0.40	0.13	0.00	0.24
Current Assets	41.91	15.56	23.58	22.52	30.15	56.58
Total Assets	45.38	15.93	23.98	22.65	30.16	56.82
Total Debt*	--	--	--	--	--	0.19
Net Current Assets	38.82	12.80	20.22	18.14	26.95	49.27

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Cash From Operating Activities	--	-12.89	-13.56	-12.18	-25.01	-37.69
Cash Flow from Investing Activities	--	--	-0.02	-0.09	--	--
Cash from Financing Activities	--	4.64	14.82	5.14	0.68	1.75
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Adjusted EPS ($)	-1.28	-1.64	-2.18	-3.82	-30.19	-33.93
Cash EPS ($)	--	-1.64	-2.17	-3.82	-30.14	-33.68
Adjusted Book Value ($)	--	1.62	3.24	4.89	6.87	45.97
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.68	-2.28	-3.26	-6.70	-35.00
Free Cash Flow per Share ($)	--	-1.68	-2.28	-3.28	-6.70	-35.00

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
ROCE (%)	--	-79.37	-68.98	-65.08	-299.07	-57.34
ROE (%)	-48.35	-79.37	-68.98	-65.08	-299.83	-57.58
ROA (%)	-37.37	-63.14	-55.58	-54.11	-259.05	-48.84
EBIT Margin (%)	-237,362.80	-4,409.16	-862.43	-2,449.59	--	--
Net Margin (%)	-237,362.80	-4,409.16	-862.43	-2,449.59	--	--
Cash Profit Margin (%)	-10.77	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Revenue Growth (%)	-99.38	-0.81	1.58	--	--	--
EBIT Growth (%)	11.14	2.77	9.30	61.77	-0.66	30.58
Net Profit Growth (%)	11.14	2.77	9.30	87.32	-208.35	32.24
EPS Growth (%)	44.60	0.25	0.43	0.87	0.11	0.33
Book Value Growth (%)	-67.38	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Price / Earnings	--	-0.52	-1.51	-1.23	-0.01	-0.08
Price / Book Value	0.26	0.53	1.01	0.96	0.05	0.06
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.35	0.64	0.25	0.28	0.74	1.35
Close Price ($)	0.80	0.85	3.29	4.70	6.62	57.40
High Price ($)	2.22	5.00	8.85	12.00	64.20	169.20
Low Price ($)	0.55	0.84	2.15	0.47	6.08	55.76
Market Cap ($ Cr)	10.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Debt to Equity	--	--	--	--	--	0.00
Short term debt to equity ratio	--	--	--	--	--	0.00
Current Ratio	13.55	5.63	7.01	5.14	9.42	7.73
Quick Ratio	13.55	--	--	--	--	--
Interest Coverage	--	--	--	--	-83.30	-22,528.70

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.00	0.01	0.06	0.02	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	17,374.46	58.95	65,082.12	29.12	4,219.25
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.